Detalhe da pesquisa
1.
VDX-111 targets proliferative pathways in canine cancer cell lines.
PLoS One
; 19(5): e0303470, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771847
2.
A noncompetitive small molecule inhibitor of estrogen-regulated gene expression and breast cancer cell growth that enhances proteasome-dependent degradation of estrogen receptor {alpha}.
J Biol Chem
; 285(53): 41863-73, 2010 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-21041310
3.
Titration of Androgen Signaling: How Basic Studies Have Informed Clinical Trials Using High-Dose Testosterone Therapy in Castrate-Resistant Prostate Cancer.
Life (Basel)
; 11(9)2021 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34575033
4.
Aberrant HOXC expression accompanies the malignant phenotype in human prostate.
Cancer Res
; 63(18): 5879-88, 2003 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14522913
5.
Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors.
Breast Cancer Res
; 7(2): R248-55, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15743505
6.
CBP recruitment and histone acetylation in differential gene induction by glucocorticoids and progestins.
Mol Endocrinol
; 17(6): 1085-94, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12637584
7.
Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cells.
Mol Endocrinol
; 16(6): 1204-14, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12040008
8.
Novel activation step required for transcriptional competence of progesterone receptor on chromatin templates.
Mol Endocrinol
; 17(12): 2543-53, 2003 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-14551264
9.
Fluorescence anisotropy microplate assay for analysis of steroid receptor-DNA interactions.
Biotechniques
; 37(5): 807-8, 810-7, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15560136
10.
Fluorescence anisotropy microplate assay to investigate the interaction of full-length steroid receptor coactivator-1a with steroid receptors.
Methods Mol Biol
; 977: 339-51, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23436375
11.
Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin.
Horm Cancer
; 4(5): 293-300, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23836117
12.
8-alkylthio-6-thio-substituted theophylline analogues as selective noncompetitive progesterone receptor antagonists.
Steroids
; 77(6): 596-601, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22421057
13.
Insertion of CTCF-binding sites into a first-generation adenovirus vector reduces the innate inflammatory response and prolongs transgene expression.
Virology
; 412(1): 136-45, 2011 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21272906
14.
HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
Mol Cancer Res
; 8(12): 1643-55, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21047772
15.
High-yield purification of functional, full-length steroid receptor coactivator 1 expressed in insect cells.
Biotechniques
; 32(2): 260, 262-3, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11848398
16.
Estrogen inhibits glucocorticoid action via protein phosphatase 5 (PP5)-mediated glucocorticoid receptor dephosphorylation.
J Biol Chem
; 284(36): 24542-52, 2009 Sep 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19586900
17.
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.
Mol Cancer Ther
; 8(5): 1055-66, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19435871
18.
A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.
J Biol Chem
; 283(19): 12819-30, 2008 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-18337247
19.
In vitro fluorescence anisotropy analysis of the interaction of full-length SRC1a with estrogen receptors alpha and beta supports an active displacement model for coregulator utilization.
J Biol Chem
; 282(5): 2765-75, 2007 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-17135255
20.
Conference report and review: current status of biomarkers potentially associated with prostate cancer outcomes.
J Urol
; 177(4): 1229-37, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17382696